Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The extracellular matrix (ECM) in skin wounds is a complex, dynamic network of proteins and polysaccharides that provides the essential structural and functional scaffold for tissue repair. It is composed of various molecules, including structural proteins like collagen and elastin, adhesive glycoproteins such as fibronectin and laminin, and proteoglycans like hyaluronan and decorin (1.1.1, 1.3.1). Beyond providing physical support, the ECM acts as a reservoir for growth factors and cytokines, regulating critical cellular processes such as adhesion, migration, and proliferation through interactions with cell-surface receptors like integrins (1.3.2, 1.3.4). In chronic wounds, the balance between ECM synthesis and degradation is often disrupted, typically involving excessive proteolysis by matrix metalloproteinases (MMPs) which hinders healing (1.1.4, 1.2.1). Conversely, abnormal ECM accumulation can lead to pathological fibrosis, resulting in hypertrophic scars or keloids (1.4.4). Therapeutic interventions targeting the ECM include enzymatic debriding agents like collagenase, bioactive dressings that provide a temporary scaffold, and agents like copper peptides that stimulate new matrix synthesis (1.3.1, 1.4.1, 1.4.2).
Provides a physical scaffold for cell migration and tissue ingrowth; sequesters and releases growth factors to modulate cellular signaling; enzymatic degradation of necrotic or damaged matrix components; induction of intracellular signaling via integrin-receptor binding.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix components in skin wounds (ECM).